![Brian Salmons](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Salmons
Algemeen Directeur bij Austrianova Singapore Pvt Ltd.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Walter H. Günzburgs | M | 65 |
Austrianova Singapore Pvt Ltd.
![]() Austrianova Singapore Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of PharmaCyte Biotech, Inc., Austrianova Singapore Pvt Ltd. is a Singaporean company that researches, develops, and produces live-cell encapsulation technologies for medical treatment. The company was founded by Walter H. Günzburgs. Brian Salmons has been the CEO of the company since 2015. | - |
Uwe Schlokat | M | - |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Ganesh Kishore | M | 70 |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | 11 jaar |
Thomas P. Monath | M | 83 |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Amiruddin Azahar | M | - |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Naser Jaafar | M | 60 |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Zainul Fadziruddin Zainuddin | M | - |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Maleisië | 6 | 85.71% |
Singapore | 1 | 14.29% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Brian Salmons
- Persoonlijk netwerk